Hemodialysis as an alternative treatment of mexiletine intoxication.

作者: Emine Akıncı , Yücel Yüzbaşıoglu , Figen Coşkun

DOI: 10.1016/J.AJEM.2010.08.027

关键词:

摘要: Mexiletine is a class IB antiarrhythmic agent. Although it primarily used in treating ventricular arrhythmias, recent indications for use of mexiletine include chronic and neuropathic pains. At high doses, causes drowsiness, confusion, nausea, hypotension, sinus bradycardia, paresthesia, seizures, bundle branch block, atrioventricular heart asystole, cardiovascular collapse, coma. A 23-year-old male patient presented to the emergency department with intentional ingestion high-dose mexiletine. Despite decontamination supportive treatment, his vitals deteriorated during observation period; he developed stupor dysarthria. Patient then underwent hemodialysis. His vital signs overall condition improved rapidly following hemodialysis treatment. In this case report, we aimed emphasize as useful alternative therapy severe intoxications.

参考文章(17)
Charles P. Denaro, Neal L. Benowitz, Poisoning due to class 1B antiarrhythmic drugs. Lignocaine, mexiletine and tocainide. Medical toxicology and adverse drug experience. ,vol. 4, pp. 412- 428 ,(1989) , 10.1007/BF03259923
R. T. Moxley, E. L. Logigian, W. B. Martens, R. T. Moxley, M. P. McDermott, N. Dilek, A. W. Wiegner, A. T. Pearson, C. A. Barbieri, C. L. Annis, C. A. Thornton, Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1 Neurology. ,vol. 76, pp. 1441- 1448 ,(2010) , 10.1212/WNL.0B013E3181DC1A3A
Susan Y. Kim, Neal L. Benowitz, Poisoning Due to Class IA Antiarrhythmic Drugs Drug Safety. ,vol. 5, pp. 393- 420 ,(1990) , 10.2165/00002018-199005060-00002
Peter Jequier, Roger Jones, Alan Mackintosh, FATAL MEXILETINE OVERDOSE The Lancet. ,vol. 307, pp. 429- 429 ,(1976) , 10.1016/S0140-6736(76)90272-5
Nobuaki Egashira, Shingo Hirakawa, Takehiro Kawashiri, Takahisa Yano, Hiroaki Ikesue, Ryozo Oishi, Mexiletine Reverses Oxaliplatin-Induced Neuropathic Pain in Rats Journal of Pharmacological Sciences. ,vol. 112, pp. 473- 476 ,(2010) , 10.1254/JPHS.10012SC
Kenji Momo, Masato Homma, Yoshiko Osaka, Shin-ichi Inomata, Makoto Tanaka, Yukinao Kohda, Effects of mexiletine, a CYP1A2 inhibitor, on tizanidine pharmacokinetics and pharmacodynamics. The Journal of Clinical Pharmacology. ,vol. 50, pp. 331- 337 ,(2010) , 10.1177/0091270009341961
Edward J. Otten, Ellenhorn's medical toxicology: Diagnosis and treatment of human poisoning, 2nd ed Journal of Emergency Medicine. ,vol. 15, pp. 582- 583 ,(1997) , 10.1016/S0736-4679(97)00099-1
U. Wiegers, P. Hanrath, K. H. Kuck, A. Pottage, C. Graffner, J. Augustin, M. Runge, Pharmacokinetics of tocainide in patients with renal dysfunction and during haemodialysis. European Journal of Clinical Pharmacology. ,vol. 24, pp. 503- 507 ,(1983) , 10.1007/BF00609893
Alec B. O'Connor, Robert H. Dworkin, Treatment of Neuropathic Pain: An Overview of Recent Guidelines The American Journal of Medicine. ,vol. 122, ,(2009) , 10.1016/J.AMJMED.2009.04.007